09:56 AM EST - MustGrow Biologics Corp. : Today announced that the board of directors of the Company authorized and approved the grant of a total of612,757 deferred share units ("DSUs") and177,035 restricted share units to certain directors, officers, and consultants of the Company, effective August 31, 2023. This grant of DSUs and RSUs is made pursuant to the Company's Omnibus Equity Incentive Plan. MustGrow Biologics Corp.
shares V.MGRO are trading unchanged at $1.54.
